| 2023-05-11 | Sale | 10x Genomics, Inc. TXG | director | 33,000 0.0286% | $52.82 | $1.74M | -12.22% | |
| 2013-07-30 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 7,000 0.0087% | $36.51 | $255,570 | -1.37% | |
| 2013-04-30 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 7,000 0.0096% | $33.74 | $236,164 | +8% | |
| 2013-02-20 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 7,000 0.0097% | $22.14 | $154,980 | +64.39% | |
| 2012-11-02 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 7,000 0.0105% | $21.45 | $150,162 | +61.06% | |
| 2012-08-13 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 25,000 0.0345% | $25.74 | $643,461 | -2.9% | |
| 2011-02-18 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 7,402 0.0126% | $23.12 | $171,134 | -2.09% | |
| 2010-09-01 | Sale | Innoviva, Inc. INVA | SVP, Research & Early Clin Dev | 8,832 0.0157% | $12.84 | $113,403 | +74.43% |